Fgf2 Rat shRNA Plasmid (Locus ID 54250)

SKU
TR710311
Fgf2 - Rat, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
  $883.00
2 Weeks*
Specifications
Specifications
Product Data
Locus ID 54250
Synonyms bFGF; Fgf-2
Vector pRS
E. coli Selection Ampicillin
Mammalian Cell Selection Puromycin
Format Retroviral plasmids
Components Fgf2 - Rat, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 54250). 5µg purified plasmid DNA per construct
29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free.
RefSeq NM_019305, NM_019305.1, NM_019305.2
UniProt ID P13109
Summary activates the MAP kinase signaling pathway; plays a role in synaptic transmission; induces cell proliferation RGD, Feb 2006
shRNA Design These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
Storage Store at -20°C
Shipping Ambient
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

Oct4-dependent FoxC1 activation improves the survival and neovascularization of mesenchymal stem cells under myocardial ischemia
Ji, Chen, Cui et al
Stem Cell Res Ther (2021) 12 (1), 483 DOI: 10.1186/s13287-021-02553-w
Cited by 12
AI Summary: In this study, OriGene products including the FoxC1 overexpression plasmid (RC211364) and Oct4 siRNA (SR307326) were used to manipulate gene expression in endothelial and mesenchymal stem cells, enabling the authors to demonstrate the critical role of the FoxC1/Oct4 axis in enhancing stem cell survival and neovascularization under ischemic conditions.
FigureFigureFigure
Oct4-dependent FoxC1 Activation Improves the Survival and Neovascularization of Mesenchymal Stem Cells under Myocardial Ischemia
Ji, Chen, Cui et al
Stem Cell Research & Therapy (2021) 12 (1) DOI: 10.1186/s13287-021-02553-w
Cited by 12
AI Summary: In this study, OriGene products Lenti-FoxC1 shRNA (TL513221V) and Lenti-Ang1 shRNA (TR711949) were used to specifically knock down FoxC1 and Ang1 gene expression, enabling the researchers to investigate their roles in mesenchymal stem cell survival and neovascularization under ischemic conditions.
Snippet: density of 5 × 104 per cm2 culture and infected with Lenti-FoxC1 shRNA (TL513221V, OriGene Technologies), Lenti 7998, GenePharma), Lenti-Ang1 shRNA (TR711949, OriGene Technologies), Lenti-bFGF shRNA (TR710311, OriGene
Showing 1-2 of 2 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products